Insider trading

Period: 120 months Stock: DNTH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

70 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

70 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

70 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

70 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
70 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
70 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

70 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Dec 2019
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$255.83K 17,055 at 15.00
67.3%
Sold half or more
10 Dec 2019
GARDNER JASON See Remarks
Sold, plan not stated
$66.32K 4,392 at 15.10
1.3%
9 Dec 2019
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$69.21K 4,614 at 15.00
35.7%
2 Dec 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 3×
$97.52K 7,500 at 13.00
3.0%
20 Nov 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$60.00K 5,000 at 12.00
2.0%
1 Nov 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$53.33K 5,000 at 10.67
1.9%
1 Oct 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$50.06K 5,000 at 10.01
1.9%
19 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$19.87K 1,656 at 12.00
0.6%
12 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$10.13K 844 at 12.00
0.3%
3 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$50.53K 5,000 at 10.11
1.8%
1 Aug 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 2×
$100.63K 7,500 at 13.42
2.7%
1 Jul 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 2×
$107.98K 7,500 at 14.40
2.6%
21 Jun 2019
GARDNER JASON See Remarks
Sold, plan not stated
$186.32K 12,331 at 15.11
3.4%
21 Jun 2019
ISACSON CHRISTINA K. Chief Business Officer
Sold, plan not stated
$87.02K 5,415 at 16.07
5.2%
20 Jun 2019
GARDNER JASON See Remarks
Sold, plan not stated
$25.20K 1,669 at 15.10
0.5%
17 Jun 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$104.27K 7,500 at 13.90
2.6%
20 Mar 2019
Booth Bruce Director · indirect
Sold, plan not stated
$254.42K 14,245 at 17.86
100%
Sold half or more
20 Mar 2019
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold, plan not stated
$254.42K 14,245 at 17.86
100%
Sold half or more
25 Jun 2018
Scadden David Director
Bought
$99.00K 6,600 at 15.00
3.0%
First buy on file
25 Jun 2018
GARDNER JASON See Remarks
Bought
$6.00K 400 at 15.00
0.1%
First buy on file
Showing 51–70 of 70. ← Newer Page 2 of 2